A detailed history of Pine Bridge Investments, L.P. transactions in United Therapeutics Corp stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 25,431 shares of UTHR stock, worth $9.14 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
25,431
Previous 1,686 1408.36%
Holding current value
$9.14 Million
Previous $537,000 1597.02%
% of portfolio
0.07%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$311.04 - $363.55 $7.39 Million - $8.63 Million
23,745 Added 1408.36%
25,431 $9.11 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $384,846 - $537,901
1,686 New
1,686 $537,000
Q3 2023

Nov 14, 2023

SELL
$211.82 - $248.24 $126,456 - $148,199
-597 Reduced 7.53%
7,329 $1.66 Million
Q2 2023

Aug 11, 2023

BUY
$205.19 - $232.99 $15,799 - $17,940
77 Added 0.98%
7,926 $1.75 Million
Q1 2023

May 12, 2023

SELL
$212.99 - $276.17 $25,132 - $32,588
-118 Reduced 1.48%
7,849 $1.76 Million
Q4 2022

Feb 09, 2023

BUY
$205.95 - $280.43 $372,357 - $507,017
1,808 Added 29.36%
7,967 $2.22 Million
Q3 2022

Nov 10, 2022

BUY
$203.3 - $244.17 $13,214 - $15,871
65 Added 1.07%
6,159 $1.29 Million
Q2 2022

Aug 05, 2022

BUY
$174.81 - $241.14 $1.07 Million - $1.47 Million
6,094 New
6,094 $1.44 Million
Q4 2020

Feb 16, 2021

SELL
$101.87 - $151.79 $3,871 - $5,768
-38 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$99.9 - $121.13 $3,796 - $4,602
38 New
38 $4,000
Q1 2018

May 14, 2018

SELL
$107.21 - $151.94 $9,434 - $13,370
-88 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$118.58 - $151.28 $948 - $1,210
8 Added 10.0%
88 $13,000
Q3 2017

Nov 13, 2017

BUY
$114.6 - $136.81 $9,168 - $10,944
80
80 $9,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Pine Bridge Investments, L.P. Portfolio

Follow Pine Bridge Investments, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.